Inhalation Sciences Sweden AB Share Price NORDIC GROWTH MARKET
Stocks
ISAB
SE0009983893
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
NORDIC GROWTH MARKET
31/01/2024
|
5-day change | 1st Jan Change | ||
| 4.340 SEK | +6.90% |
|
-.--% | - |
| 22/09 | Inhalation Sciences ends M&A process, changes CEO | FW |
| 28/08 | Inhalation Sciences receives SEK 0.5m from warrants | FW |
| Market Cap | 48.64L 5L 4L 4L 4L 7L 4.7Cr 7L 18.86L 2.4Cr 18.43L 18.03L 7.77Cr | P/E 2024 |
-12.8x | P/E 2025 | -12.4x |
|---|---|---|---|---|---|
| Enterprise Value | 20.33L 2L 2L 2L 2L 3L 1.96Cr 3L 8L 1Cr 8L 8L 3.25Cr | EV / Sales 2024 |
5.6x | EV / Sales 2025 | 55x |
| Free-Float |
99.4% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +6.90% |
| Manager | Title | Age | Since |
|---|---|---|---|
Manoush Masarrat
CEO | Chief Executive Officer | - | 16/09/2019 |
Per Magnus Gerde
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2005 |
Ulf Wedenberg
PRN | Corporate Officer/Principal | - | 02/06/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Per Magnus Gerde
BRD | Director/Board Member | - | 01/01/2005 |
Jan Hellqvist
BRD | Director/Board Member | - | 01/09/2022 |
Ulf Ericsson
BRD | Director/Board Member | - | 01/09/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.90% | -.--% | - | - | 5L | |
| +1.03% | +2.60% | +41.63% | +32.32% | 24TCr | |
| +0.21% | +6.34% | +16.78% | -10.79% | 16TCr | |
| -0.94% | +4.19% | -11.04% | +38.20% | 14TCr | |
| -0.67% | +1.62% | -54.32% | -16.75% | 6.51TCr | |
| -2.21% | -2.76% | +16.43% | +24.63% | 5.12TCr | |
| -0.61% | -3.02% | -20.99% | -21.63% | 4.77TCr | |
| -1.16% | +7.57% | +31.27% | +48.39% | 4.72TCr | |
| -1.21% | +0.46% | +40.56% | +56.35% | 4.18TCr | |
| +3.20% | +11.55% | +157.00% | +92.83% | 3.74TCr | |
| Average | +0.45% | +2.74% | +24.15% | +27.06% | 9.24TCr | |
| Weighted average by Cap. | -0.03% | +2.88% | +19.87% | +22.69% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.1Cr 11.15L 10L 9L 8L 15.71L 11Cr 15.83L 42.83L 5.44Cr 41.86L 40.94L 18Cr | 30.41L 3L 3L 3L 2L 4L 2.94Cr 4L 11.79L 1.5Cr 11.52L 11.27L 4.86Cr |
| Net income | -51.47L -5L -5L -4L -4L -7L -4.98Cr -7L -19.95L -2.54Cr -19.5L -19.08L -8.22Cr | -1.02Cr -10.25L -9L -8L -8L -14.45L -9.82Cr -14.56L -39.39L -5.01Cr -38.5L -37.66L -16Cr |
| Net Debt | -40.03L -4L -4L -3L -3L -6L -3.87Cr -6L -15.52L -1.97Cr -15.17L -14.84L -6.4Cr | -28.31L -3L -3L -2L -2L -4L -2.74Cr -4L -10.98L -1.4Cr -10.73L -10.49L -4.52Cr |
Employees
-
Net sales - Rate of surprise
- Stock Market
- Stocks
- ISAB Stock
- ISAB Stock
Select your edition
All financial news and data tailored to specific country editions
